Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.

N GARDINER, M LAWLER… - Leukemia  …, 1997 - search.ebscohost.com
chimaerism test to monitor patients post BMT for CML. We wished to investigate if donor
chimaerism is a good indicator of disease free survival … Therefore we evaluated both chimaerism

Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia

C Schneidawind, V Hagmaier, C Faul, L Kanz… - Annals of …, 2018 - Springer
… acute myeloid leukemia (AML) and acute lymphoblastic leukemia (… disease relapse since
we excluded graft failure as indication … , and time from transplant to full donor chimerism had no …

Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia

M Barrios, A Jiménez-Velasco, J Román-Gómez… - …, 2003 - haematologica.org
… tained complete donor chimerism (CC) over the whole follow-… allogeneic SCT for chronic
myeloid leukemia (CML), our … bone marrow transplantation for chronic myelogenous leukemia. …

Impact on outcomes of mixed chimerism of bone marrow CD34+ sorted cells after matched or haploidentical allogeneic stem cell transplantation for myeloid …

Y Le Bris, D Costes, R Bourgade, T Guillaume… - … Marrow Transplantation, 2022 - nature.com
… be monitored by assessing the chimerism of donor (D) and … in about two thirds of acute
myeloid leukemia (AML) patients [… for acute or chronic myeloid disease, between October 2009 …

Quantitative chimerism: an independent acute leukemia prognosis indicator following allogeneic hematopoietic SCT

XY Qin, GX Li, YZ Qin, Y Wang, FR Wang… - … Marrow Transplantation, 2014 - nature.com
Disease-free survival (DFS) was described as the probability … increasing chimerism accepted
mDLI based on donor availability… myeloid leukemia for patients showing evidence of mixed …

[HTML][HTML] Characterization of mixed chimerism in patients with chronic myeloid leukemia transplanted with T-cell-depleted bone marrow: involvement of different …

E Roux, K Abeti, D Speiser, C Helg, B Chapuis… - Blood, 1993 - Elsevier
… of leukocytes and analyzed their donor/recipient origin by a method … AFTER BONE marrow
transplantation (BMT) incomplete … is essential for leukemic-free survival. One could argue that …

… Blood CD34 Donor Chimerism has Greater Clinical Utility Than CD3 for Detecting Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or …

TP Das, D North, SA Fleming, JLC Tan, A Ivey… - Transplantation and …, 2023 - Elsevier
… In July 2011, the Alfred Hospital Bone Marrow Transplantation Service … Overall survival and
relapse-free survival (RFS) were … the CD34 + DC sample to measure NPM1 mut , a molecular …

Persistence of host-type hematopoiesis after allogeneic bone marrow transplantation for leukemia is significantly related to the recipient's age and/or the conditioning …

JE Van Leeuwen, MJ Van Tol, AM Joosten, JT Wijnen… - 1994 - ashpublications.org
chimerism following allogeneic bone marrow transplantationtransplantation in patients with
chronic myeloid leukemia in … rism and leukemia relapse in chronic myelogenous leukemia

Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation

…, EBMT Immunology and Chronic Leukemia … - Vox …, 1998 - Wiley Online Library
… GVHD on leukemia-free survival be evaluated [ 101. In … mixed chimerism is converted to
complete donor type chimerism after … for chronic myeloid leukemia: is T cell dose important in …

Chimerism and clinical outcomes of 110 recipients of unrelated donor bone marrow transplants who underwent conditioning with low-dose, single-exposure total body …

M Girgis, C Hallemeier, W Blum, R Brown, H Lin… - Blood, 2005 - ashpublications.org
… Overall and disease-free survival rates in the good risk group were … 1400 patients with chronic
myelogenous leukemia (CML) … following diagnoses were eligible: acute myeloid leukemia (…